Purpose: The isotope 123 I is commonly labeled with meta-iodobenzylguanidine (mIBG) for imaging of neuroendocrine tumors, such as pheochromocytomas and neuroblastomas.
INTRODUCTION
Meta-iodobenzylguanidine (mIBG) is an analog of noradrenaline which is actively taken up by neuroendocrine tumor cells by the noradrenaline transporting protein. Therefore, mIBG is routinely labeled with iodine-123 ( 123 I) for diagnosis or iodine-131 ( 131 I) for therapy of neuroendocrine tumors such as pheochromocytomas, paragangliomas, and neuroblastomas, the most frequent pediatric soft tissue tumor. 1-3 123 I is a gamma emitter and is routinely used for pretherapeutic imaging because of the medium energy photopeak at 159 keV, which is well-suited for SPECT and scintigraphic imaging. 4, 5 Alternatively, iodine-124 ( 124 I) is rapidly emerging as an isotope for diagnostic imaging. [6] [7] [8] [9] [10] Since 124 I is a positron emitter, imaging is performed using a Positron Emission Tomography (PET) scanner. PET is known for its superior resolution, sensitivity and quantitation as compared with scintigraphy or SPECT, which is used for 123 I. The half-life of 124 I (4.2 days) allows assessment of tracer kinetics over a prolonged period, in contrast to 123 I, with a short half-life of 13.2 h. However, due to a longer half-life and the emitted high energy photons, the effective radiation dose is 20 to 30 times higher for 124 I (0.25-1.03 mSv/MBq) than for 123 I (0.013-0.037 mSv/MBq), which should be taken into account, especially for pediatric applications. 11 For pretherapeutic 124 I imaging of suspected recurrence of differentiated thyroid carcinoma, we previously showed that a low activity of 124 I (~1% of therapeutic 131 I activity) is sufficient to achieve similar image quality on pretherapeutic 124 I PET/CT and post-therapeutic 131 I SPECT/CT for small lesions (≤ 10 mm). 12 However, discrepancies between pretherapeutic 124 I PET/CT and post-therapeutic 131 I SPECT/ CT may be ascribed to differences in detectability for large lesions.
The purpose of this study was to investigate whether 124 I PET/CT is a viable alternative for 123 I SPECT/CT with respect to image quality and patient effective radiation dose and, hence, to determine whether we can improve image quality and/or reduce the effective patient dose by replacing 123 I-mIBG SPECT/CT with 124 I-mIBG PET/CT. Therefore, we established the ratio of 123 I and 124 I activity concentration at which the contrast-to-noise ratio was equal for both modalities.
MATERIALS AND METHODS

2.A. Phantom
123 I SPECT/CT and 124 I PET/CT acquisitions of the IEC NEMA 2007 phantom (PTW Freiburg GmbH, Freiburg, Germany) were used for the analysis of image quality. The IEC NEMA 2007 phantom has a lid holding refillable thinwalled spheres of 10, 13, 17, 22, 28, and 37 mm in diameter and is torso-shaped. Separate phantoms were used for the analysis of 124 I and 123 I image quality. Different activity concentrations were obtained by leaving the activity to decay to reduce measurement errors as compared with refilling the phantom. Phantoms were used with a 10:1 sphere-to-background ratio.
Activity concentrations ranging from 1.8 9 10 4 Bq/ml to 4.6 Bq/ml for 124 I and from 7.3 9 10 5 Bq/ml to 3.4 9 10 2 Bq/ml for 123 I in the spheres were used. The initial activity concentration is demonstrated in Table I. Forty-five  124 I PET acquisitions and 42 123 I SPECT acquisitions were obtained over a period of 50 days and 7 days, respectively.
2.B. Scanners and acquisition
PET/CT images were obtained using a Siemens Biograph mCT Time-of-flight (TOF) PET/CT scanner (Siemens Healthcare, Erlangen, Germany) with TrueV and an axial field-ofview of 21.6 cm. An energy window of 435 to 650 keV was used and 124 I images were acquired in 4 min per bed position. As an acquisition with a single bed position does not result in a field-of-view with a uniform axial sensitivity, three bed positions were used. This protocol allows comparison with other studies conducted in our institution. [12] [13] [14] [15] SPECT/CT images were acquired on a dual-headed Siemens Symbia T16 (Siemens Healthcare, Erlangen, Germany) with a Low and Medium Energy General Purpose (LMEGP) (Nuclear Fields BV, Vortum-Mullem, The Netherlands) collimator. The LMEGP collimator has 24785 holes, a hole length of 37 mm, hole diameter of 2.5 mm and septal thickness of 0.6 mm. Sixty-four projections were acquired with a 50 s acquisition time per view resulting in a total acquisition time of 26 min. The 123 I images were acquired on a 128 9 128 grid with a 3.9 9 3.9 mm 2 pixel size. The acquisitions and reconstructions were performed in accordance with our clinical protocol and as advised by the vendor. and a randoms correction were incorporated in the reconstruction method. The Gaussian-filtered randoms-sinogram was added to the forward projection during the iterative reconstruction. 17 All images were reconstructed using CTbased attenuation correction, scatter correction and a Gaussian postreconstruction filter was applied with a full width at half maximum of 5 mm. In addition, 124 I PET images were reconstructed using the following two settings.
2.C. Reconstruction
The first method was an ordered subset expectation maximization 3D-reconstruction method using four iterations and 21 subsets. Time-of-flight (TOF) information (TrueX) with point-spread-function (PSF) model-based resolution recovery was incorporated in the reconstruction method. The reconstructions were performed in accordance with the clinical protocol. [12] [13] [14] This method is defined as the PSF TOF method.
The second method was an ordered subset expectation maximization 3D reconstruction method using four iterations and 24 subsets. No-TOF modeling and no-PSF model-based resolution recovery were incorporated. The number of iterations were performed as advised by the vendor for this setting. This reconstruction method is defined as the no-PSF no-TOF method.
The 123 I SPECT reconstruction method created SPECT images with 3.9 9 3.9 9 3.9 mm 3 voxel size on a 128 9 128 9 101 grid. CT-based attenuation correction and resolution recovery using distance-dependent PSFs were incorporated in the Siemens Flash 3D reconstruction algorithm. SPECT images were reconstructed using four reconstruction methods, using (a) six iterations with eight subsets and triple-energy-window scatter correction (SC 6i8s), (b) six iterations with eight subsets without scatter correction (no-SC 6i8s), (c) 30 iterations with eight subsets and triple-energy-window scatter correction (SC 30i8s) and (d) 30 iterations with eight subsets without scatter correction (no-SC 30i8s).
2.D. Quantitative analysis
The contrast-to-noise ratio (CNR) was calculated as a measure of image quality using
where C H is the mean voxel value in the sphere volume of interest (VOI), C B is the mean voxel value in the background VOI and r B is the standard deviation in the background VOI.
The contrast-to-noise ratio is a meaningful image quality parameter in this context, as the ability to detect lesions/hot spots depends on intensity of the hot spot, intensity of the background and the noise in the background. On the basis of the sphere coordinates determined from the co-registered CT, three-dimensional VOI masks were created. The sphere coordinates were determined automatically using a Hough-transform-based circle detection method in the CT image. 18 The entire phantom excluding the sphere VOIs was defined as the background VOI. A 2 cm margin around the spheres and the phantom edges was subtracted from the background VOI by means of binary erosion to prevent errors in the background measurement due to partial volume effects.
The ratio between the 123 I and the 124 I activity concentration required to achieve the same CNR was calculated and was defined as the Contrast Equivalent Activity Ratio (CEAR). This metric was calculated to assess the difference in image quality of 124 I PET/CT and 123 I SPECT/CT images. For example, a CEAR of 10 is obtained when the 123 I activity concentration required to achieve the same CNR is 10 times higher than the 124 I activity concentration. The average ratio of the 123 I and 124 I CNR curves (CNR versus activity concentration) was calculated to obtain the CEAR for each sphere size. A least-squares fit of the CNR curves was performed to reduce the influence of noise on the calculated CEARs. As the CNR curves covered several orders of magnitude, cubic spline interpolation was performed in the log-log domain.
2.E. Effective dose
The effective dose of the administered activity in mSv per MBq is higher for 124 I than for 123 I. Therefore, a lower activity of 124 I should be administered when striving for an equal or lower effective dose. This makes the improvement of image quality with 124 I PET/CT as compared with 123 I SPECT/CT imaging a challenge. Table II shows that the effective dose of the administered activity in mSv per MBq is 20 to 30 times higher for 124 I-mIBG than for 123 I-mIBG, depending of the weight of the patient. As a result, a 20 to 30 times lower 124 I-mIBG activity should be administered to make sure the patient does not receive a higher effective patient dose than the patient would receive with 123 I-mIBG, assuming that the scan is performed directly after the administration of activity. However, we should take into consideration that imaging of the 124 I and 123 I activity is performed 24 h after injection. As 123 I has a much shorter decay time (T ½ = 13.2 h) than 124 I (T ½ = 4.18 d), a relatively large part of the 123 I activity has been decayed at the time of the scan. Consequently, the 123 I activity concentration corrected for decay is only 5 to 10 times (instead of 20 to 30 times) higher than the 124 I concentration for equal effective dose when imaging is performed 24 hours after injection, as shown in Table II . Improvement of image quality with 124 I PET/CT as compared with 123 I SPECT/CT imaging can therefore be achieved for an equal or lower effective patient dose when the CEAR is larger than a factor of 5 to 10.
RESULTS
First,
124 I PET/CT and 123 I SPECT/CT phantom acquisitions were performed for different activity concentrations (representative examples; Figs. 1 and 2) . Subsequently, the sphere CNR was plotted as a function of activity concentration in the spheres for 124 I and 123 I phantom with background for spheres with a diameter of 10-17 mm (Fig. 3 ) and for spheres with a diameter of 22-37 mm (Fig. 4) . This shows that a higher 123 I activity concentration was required to achieve the same CNR. The ratio of 123 I and 124 I activity concentration at which the contrast-to-noise ratio was equal for both modalities (i.e. the CEAR) was determined for each sphere size and for each combination of PET and SPECT reconstruction methods as shown in Table III .
The effective dose of the administered activity in mSv per MBq is higher for I SPECT/CT imaging can be achieved for an equal or lower effective patient dose when the CEAR is larger than a factor of 5 to 10, as shown in Table II . Table III shows that the CEAR is much larger than a factor of 5 to 10 for most of the reconstruction methods and sphere sizes. Table III shows that the CEAR is in the range of 5 to 10 for some reconstruction methods and sphere sizes. This is only the case for sphere sizes larger than 22 mm. As lesions are generally expected to be smaller than 22 mm, 124 I PET/ CT is expected to improve image quality as compared with 123 I SPECT/CT regardless of the reconstruction method used.
DISCUSSION
The purpose of this study was to investigate whether 124 I PET/CT is a viable alternative for 123 I SPECT/CT with respect to image quality and patient effective radiation dose.
The ratio between the 123 I and the 124 I activity concentration required to achieve the same CNR was calculated and was defined as the Contrast Equivalent Activity Ratio (CEAR). The CEAR is much larger than a factor of 5 to 10 for most of the reconstruction methods and sphere sizes. Therefore, 124 I PET/CT is expected to improve image quality as compared with 123 I SPECT/CT in these cases. 124 I PET/CT holds other advantages over 123 I SPECT/CT in clinical practice. Firstly, delayed scanning of 124 I may prove to be an advantage due to a potential increase of the lesion-to-background contrast over time. 4 Bq/ml and (c) 4.0 9 10 2 Bq/ml in the spheres. The images were reconstructed using the SC 6i8s method. The maximum of the gray scale is five times the mean pixel value of the image. I (squares) phantom with background for spheres with a diameter of (a) 10 mm, (b) 13 mm, and (c) 17 mm. The CEAR is determined by calculating the ratio of the curves, which is graphically represented as the horizontal distance between the curves. The gray lines denote the interval where the average ratio between the curves was determined. PET images were reconstructed using the PSF TOF method and SPECT images using the SC 6i8s method. 4 Bq/ml, (b) 9.3 9 10 2 Bq/ml and (c) 6.5 9 10 1 Bq/ml in the spheres. The images were reconstructed using the PSF TOF method. The maximum of the gray scale is five times the mean pixel value of the image.
123 I-mIBG scanning may occasionally depict additional lesions, but is generally believed to decrease image quality. 20 As the half-life of 123 I is 13.2 h, the interval between the administration and 123 I acquisition should ideally not exceed 24 h. The half-life of 124 I is much longer (4.18 days), which is why delayed scanning of 124 I may prove to be an advantage I (squares) phantom with background for spheres with a diameter of (a) 22 mm, (b) 28 mm, and (c) 37 mm. The CEAR is determined by calculating the ratio of the curves, which is graphically represented as the horizontal distance between the curves. The gray lines denote the interval where the average ratio between the curves was determined. PET images were reconstructed using the PSF TOF method and SPECT images using the SC 6i8s method. [Color figure can be viewed at wileyonlinelibrary.com] 
124
I PET/CT and 123 I SPECT/CT acquisitions with comparable CNR values (CNR%8) for spheres with a diameter of (a) and (g) 10 mm, (b) and (h) 13 mm and (c) and (i) 17 mm, (d) and (j) 22 mm, (e) and (k) 28 mm and (f) and (l) 37 mm, for 124 I and 123 I, respectively. PET images were reconstructed using the PSF TOF method and SPECT images using the SC 6i8s method. The maximum of the gray scale is five times the mean pixel value of the image. of 124 I over 123 I. Secondly, the acquisition times of PET as compared with SPECT are generally shorter. In this study, the SPECT acquisition time was 26 min covering a field-of-view of approximately 40 cm. For PET, the acquisition of three bed positions corresponded to a comparable field-of-view and was performed in only 12 minutes. Especially in pediatric applications, short acquisition times are an advantage since motion artifacts are reduced and/or prolonged anesthesia can be prevented. Disadvantages of 124 I include the high costs and the limited availability, although this is rapidly changing owing to the increasing number of cyclotrons that are being installed in hospitals.
The comparison of on the basis of effective dose only takes into consideration the difference in physical half-life of 124 I and 123 I. In clinical practice, the effective half-life also affects the activity concentration and, hence, the image quality. Differences in the uptake, retention and washout of 124 I and 123 I may occur, which should be taken into account when comparing clinical 124 I PET/CT and 123 I SPECT/CT images. Note that the CEAR values presented in Table III are only affected by the physical half-life.
Our findings are in agreement with literature regarding the image quality of 123 I SPECT and 124 I PET. In that, Rault et al. have shown that the 124 I PET outperforms 123 I SPECT in the sense of contrast recovery. 21 They ascribed the improvement of image quality to the principle of electronic collimation employed in PET. Apart from investigating image quality, our study also considers radiation dose, and evaluates both factors quantitatively. In general, radiation dose should be considered when evaluating novel methods in clinical practice, especially in pediatric medicine.
A lesion is no longer visible when the activity falls below the threshold that sufficient signal is acquired to distinguish the lesion from the background. This detection threshold is also referred to as the minimum detectable activity (MDA), which can be quantified by performing observer studies or by using the Rose criterion. [22] [23] [24] The Rose criterion states that a lesion is no longer visible when the CNR of the lesion falls below a certain threshold value. Discrepancies between 124 ImIBG and 123 I-mIBG studies may occur when the activity falls below the MDA for one of the studies, but not for the other. Therefore, the average ratio of the 123 I and 124 I cubic spline fits was calculated over the largest available range of data points where CNR data were acquired for both isotopes. However, data points with a CNR lower than 1 are a consequence of a low number of counts, are inherently noisy and fall below the MDA. Therefore, CNR values lower than 1 were ignored for cubic spline interpolation and, hence, not used to determine the CEAR.
Phantoms were used with a 10:1 sphere-to-background ratio for image quality analysis. In a phantom, it may be difficult to simulate the lesion-to-background ratio observed in clinical practice, as uptake ratios show large inter and intra patient variations. 25, 26 This is a drawback of phantom studies in general. However, we have previously observed that the sphere-to-background ratio does not significantly affect the relative differences in image quality (i.e., the CEAR) when comparing the image quality of two isotopes.
12 Activity concentrations ranging from 1.8 9 10
4 Bq/ml to 4.6 Bq/ml for 124 I and from 7.3 9 10 5 Bq/ml to 3.4 9 10 2 Bq/ml for 123 I in the spheres were used. At the beginning of the experiment, we used 19.8 MBq of 124 I and 833 MBq of 123 I in a phantom of approximately 10 kg, resulting in initial activities higher than typically administered in clinical practice. That is, activities of 400 MBq 123 I-mIBG for a patient of 70 kg are recommended. 27 Guidelines for the use of 124 I-mIBG do not exist, but activities of 25-74 MBq 124 I sodium iodide for an average adult patient are generally used. [28] [29] [30] [31] [32] [33] After filling the phantom, we let the activity decay to concentrations well below the point that the spheres in the phantom could be discerned. In this way, the range of activities that could be encountered in clinical practice was covered.
Uncertainties in the activity measurements of dose calibrators should be taken into account when interpreting these results. Relative measurement errors of approximately 5% are no exception, even when sufficient precautions are taken. Table II ). The ratio between the 124 I and 123 I activity concentration was (a) and (g) 7.6, (b) and (h) 6.6, (c) and (i) 9.2, (d) and (j) 6.8, (e) and (k) 8.8 and (f) and (l) 7.2. PET images were reconstructed using the PSF TOF method and SPECT images using the SC 6i8s method. The maximum of the gray scale is five times the mean pixel value of the image.
As the calculated CEAR values are affected by measurement errors in the activity measurements of both isotopes, uncertainties in the CEARs of approximately 10% should be taken into account.
The reconstruction methods using six iterations and eight subsets were performed to allow comparison with studies performed using our clinical 123 I-mIBG protocol and as advised by the vendor. The reconstruction methods using 30 iterations and eight subsets were performed as a higher number of iterations is generally used for quantitative imaging, although increased contrast recovery comes at the cost of increased image noise. 35, 36 The number of iterations that should be used in clinical practice therefore depends on the application. For dosimetry, a larger number of iterations may be favorable, whereas a lower noise level may be required for optimal detectability. In practice, several reconstruction methods are often performed for the same study. The same holds for scatter correction. Scatter correction may improve contrast but also increases noise levels. Table II shows that the CEAR is smaller for SPECT reconstruction methods with scatter correction than without scatter correction, except for the smallest sphere (10 mm). This shows that scatter correction improves the CNR of large lesions but decreases the CNR of small lesions. Therefore, reconstructions were included with and without scatter correction.
In summary, the CEAR is much larger than a factor of 5 to 10 for most of the reconstruction methods and sphere sizes, especially for small spheres (< 22 mm). Our results suggest that 124 I-mIBG activities may be used that are 10 times lower than the 123 I-mIBG activity. EANM guidelines recommend the use of 37-476 MBq 123 I mIBG, depending on the weight of the patient. Therefore, 124 I-mIBG activities as low as 3.7-48 MBq are recommended, depending on the weight of the patient. This would result in a comparable or lower effective radiation dose and an improvement of 124 I-mIBG PET image quality as compared with 123 I-mIBG SPECT. However, the availability and cost of 124 I could hamper clinical implementation.
CONCLUSIONS
The contrast equivalent activity ratio (CEAR) is larger than a factor of 5 to 10 for most of the reconstruction methods and sphere sizes. Therefore, 124 I-mIBG PET/CT is expected to improve image quality and/or may be used to reduce effective patient dose as compared with 123 I-mIBG SPECT/CT. 124 I-mIBG activities as low as 3.7-48 MBq are recommended, depending on the weight of the patient.
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